APA (7th ed.) Citation

A, L., E, B., J, S., F, C., CM, Z., & F, B. (2026). Incorporating Immunotherapies into the Evolving Standard of Care for Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. Paediatric drugs. https://doi.org/10.1007/s40272-026-00761-6

Chicago Style (17th ed.) Citation

A, Lissat, Brivio E, Stutterheim J, Calkoen F, Zwaan CM, and Bautista F. "Incorporating Immunotherapies into the Evolving Standard of Care for Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia." Paediatric Drugs 2026. https://doi.org/10.1007/s40272-026-00761-6.

MLA (9th ed.) Citation

A, Lissat, et al. "Incorporating Immunotherapies into the Evolving Standard of Care for Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia." Paediatric Drugs, 2026, https://doi.org/10.1007/s40272-026-00761-6.